Trial site
Tokai University Hospital
- 25running trials
- 14closed trials
The trials here
What the 39 trials at this site are about, from their registry records.
- Conditions
- Metastatic breast cancer5 trials
- Atrial fibrillation3 trials
- Myeloproliferative neoplasms3 trials
- Psoriasis3 trials
- Antiphospholipid syndrome2 trials
- Chronic kidney disease2 trials
- Chronic lymphocytic leukaemia2 trials
- Coronary artery disease2 trials
- Dermatomyositis and polymyositis (myositis)2 trials
- Heart failure2 trials
- Immune thrombocytopenia (ITP)2 trials
- Irritable bowel syndrome2 trials
- and 14 more
- Phase
- Phase 319 trials
- Phase 27 trials
- Phase 13 trials
- Phase 1/22 trials
- Phase 42 trials
- Phase 2/31 trial
- Status
- Active, not recruiting12 trials
- Recruiting12 trials
- Completed11 trials
- Terminated3 trials
- Enrolling by invitation1 trial
- Lead sponsor
- Janssen Research & Development, LLC8 trials
- Eli Lilly and Company4 trials
- Incyte Corporation3 trials
- Boehringer Ingelheim2 trials
- Chugai Pharmaceutical2 trials
- and 18 more
Running trials
Recruiting
Recruiting
A Phase 2 Bridging Study of Elacestrant Monotherapy in Advanced or Metastatic Breast Cancer
Recruiting
A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Diarrhea (IBS-D)
Recruiting
Recruiting
Recruiting
A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
Recruiting
Recruiting
Non-antithrombotic Versus. Single Antiplatelet Therapy Following Left Atrial Appendage Closure
Active, not recruiting
Enrolling by invitation
Phase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial)
Active, not recruiting
Active, not recruiting
Recruiting
Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
Recruiting
Active, not recruiting
A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis
Recruiting
A Phase III Study of CLS2901C in Patients With Osteoarthritis of the Knee
Active, not recruiting
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Ponatinib Versus Imatinib in Adults With Acute Lymphoblastic Leukemia
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Metastatic breast cancer4 recruiting
- Antiphospholipid syndrome2 recruiting
- Dermatomyositis and polymyositis (myositis)2 recruiting
- Immune thrombocytopenia (ITP)2 recruiting
- Irritable bowel syndrome2 recruiting
- Atrial fibrillation1 recruiting
- Chronic lymphocytic leukaemia1 recruiting
- Colorectal cancer1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Heart failure1 recruiting
- Lupus (SLE)1 recruiting
- Osteoarthritis1 recruiting
Closed trials
Completed
Completed
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome
Terminated
A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE
Completed
Terminated
Terminated
Completed
Completed
Completed
Completed
Completed
Completed
Efficacy and Safety Study of bb2121 in Subjects With Relapsed and Refractory Multiple Myeloma
Completed
Clinical Trial of Cilostazol Eluting Stent System (CES-1) in De Novo Coronary Artery Lesions
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026